These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36713571)

  • 41. A Tumor Progression Related 7-Gene Signature Indicates Prognosis and Tumor Immune Characteristics of Gastric Cancer.
    Liu F; Yang Z; Zheng L; Shao W; Cui X; Wang Y; Jia J; Fu Y
    Front Oncol; 2021; 11():690129. PubMed ID: 34195091
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Construction of anoikis-related lncRNAs risk model: Predicts prognosis and immunotherapy response for gastric adenocarcinoma patients.
    Li Q; Zhang H; Hu J; Zhang L; Zhao A; Feng H
    Front Pharmacol; 2023; 14():1124262. PubMed ID: 36925640
    [No Abstract]   [Full Text] [Related]  

  • 43. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer.
    Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J
    Front Genet; 2021; 12():661306. PubMed ID: 34249086
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer.
    Yang X; Weng X; Yang Y; Zhang M; Xiu Y; Peng W; Liao X; Xu M; Sun Y; Liu X
    Aging (Albany NY); 2021 Aug; 13(15):19486-19509. PubMed ID: 34341184
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification of anoikis-related molecular patterns to define tumor microenvironment and predict immunotherapy response and prognosis in soft-tissue sarcoma.
    Qi L; Chen F; Wang L; Yang Z; Zhang W; Li ZH
    Front Pharmacol; 2023; 14():1136184. PubMed ID: 36937870
    [No Abstract]   [Full Text] [Related]  

  • 46. Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.
    Jia X; Chen B; Li Z; Huang S; Chen S; Zhou R; Feng W; Zhu H; Zhu X
    Front Oncol; 2021; 11():799223. PubMed ID: 35096599
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Construction of a novel anoikis-related prognostic model and analysis of its correlation with infiltration of immune cells in neuroblastoma.
    Chen J; Sun M; Chen C; Kang M; Qian B; Sun J; Ma X; Zhou J; Huang L; Jiang B; Fang Y
    Front Immunol; 2023; 14():1135617. PubMed ID: 37081871
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel immunogenomic signature to predict prognosis and reveal immune infiltration characteristics in pancreatic ductal adenocarcinoma.
    Li A; Ye B; Lin F; Wang Y; Miao X; Jiang Y
    Precis Clin Med; 2022 Jun; 5(2):pbac010. PubMed ID: 35694712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
    Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
    J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A lactate-related LncRNA model for predicting prognosis, immune landscape and therapeutic response in breast cancer.
    Li J; Zhang Y; Li C; Wu H; Feng C; Wang W; Liu X; Zhang Y; Cai Y; Jia Y; Qiao H; Wu F; Zhang S
    Front Genet; 2022; 13():956246. PubMed ID: 36276952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of the angiogenesis related genes for predicting prognosis of patients with gastric cancer.
    Zheng S; Zhang Z; Ding N; Sun J; Lin Y; Chen J; Zhong J; Shao L; Lin Z; Xue M
    BMC Gastroenterol; 2021 Apr; 21(1):146. PubMed ID: 33794777
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a novel hypoxia-immune-related LncRNA risk signature for predicting the prognosis and immunotherapy response of colorectal cancer.
    Luan L; Dai Y; Shen T; Yang C; Chen Z; Liu S; Jia J; Li Z; Fang S; Qiu H; Cheng X; Yang Z
    Front Immunol; 2022; 13():951455. PubMed ID: 36189298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Construction of a cancer-associated fibroblasts-related long non-coding RNA signature to predict prognosis and immune landscape in pancreatic adenocarcinoma.
    Ye Y; Zhao Q; Wu Y; Wang G; Huang Y; Sun W; Zhang M
    Front Genet; 2022; 13():989719. PubMed ID: 36212154
    [No Abstract]   [Full Text] [Related]  

  • 56. A Four Autophagy-Related Gene-Based Prognostic Signature for Pancreatic Cancer.
    Zhou Q; Chen X; Chen Q; Liu H; Hao L
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):89-100. PubMed ID: 34587439
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a novel signature based on unfolded protein response-related gene for predicting prognosis in bladder cancer.
    Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
    Hum Genomics; 2021 Dec; 15(1):73. PubMed ID: 34930465
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
    Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
    Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
    [No Abstract]   [Full Text] [Related]  

  • 59. [Construction and Validation of Prognostic Risk Score Model of Autophagy Related Genes in Lung Adenocarcinoma].
    Zhou J; Wang X; Li Z; Jiang R
    Zhongguo Fei Ai Za Zhi; 2021 Aug; 24(8):557-566. PubMed ID: 34256900
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Significance of a Tumor Mutation Burden Gene Signature with Prognosis and Immune Feature of Gastric Cancer Patients.
    Xiang L; Lan C
    Int J Genomics; 2022; 2022():7684606. PubMed ID: 35719415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.